GPC Forms US Subsidiary, Recruits Two Executives

May 06, 1999

Premium

MUNICH--GPC, a second-generation genomics-based drug discovery company, has created a US subsidiary, GPC USA, based in Princeton, NJ. John Richard has been named US business development advisor and Gregory Hamm is vice-president of bioinformatics and US site head.

Richard's background includes developing strategic alliances in genomics, drug discovery, and drug delivery. He has been executive vice-

president at Sequus Pharmaceuticals and head of business development at Vivus and at Genome Therapeutics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Main menu